Oncolytics Biotech (ONCY) Tops Q3 EPS by 3c
Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.09), $0.03 better than the analyst estimate of ($0.12).
For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.
Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.09), $0.03 better than the analyst estimate of ($0.12).
For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.